Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma.
Fiche publication
Date publication
novembre 2023
Journal
Journal for immunotherapy of cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr GEOFFROIS Lionnel
Tous les auteurs :
de Vries-Brilland M, Rioux-Leclercq N, Meylan M, Dauvé J, Passot C, Spirina-Menand E, Flippot R, Fromont G, Gravis G, Geoffrois L, Chevreau C, Rolland F, Blanc E, Lefort F, Ravaud A, Gross-Goupil M, Escudier B, Negrier S, Albiges L
Lien Pubmed
Résumé
Papillary renal cell carcinoma (pRCC) is the most common non-clear cell RCC, and associated with poor outcomes in the metastatic setting. In this study, we aimed to comprehensively evaluate the immune tumor microenvironment (TME), largely unknown, of patients with metastatic pRCC and identify potential therapeutic targets.
Mots clés
Gene Expression Profiling, Immunotherapy, Renal Cell Carcinoma, Tumor Biomarkers, Tumor Microenvironment
Référence
J Immunother Cancer. 2023 11;11(11):